Pashtoon Kasi, MD, MS, explains how liquid biopsy next-generation sequencing (NGS)-based testing can benefit cancer patients. Dr. Kasi presents four colorectal cancer patient cases for whom comprehensive genomic profiling (CGP) was done via liquid biopsy and results for clinically-relevant biomarkers were obtained in 7-8 days.
Audio PlayerFor the best experience using our website, we recommend that you upgrade to a newer version or use another web browser. A list of the most popular web browsers can be found below.
Click on an icon below to go to the download page or close this notice to continue with the current experience.